Bokf, Na Gilead Sciences, Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bokf, Na holds 106,575 shares of GILD stock, worth $9.74 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

106,575

Previous 112,534 5.3%

Holding current value

$9.74 Million

Previous $7.72 Million 15.71%

% of portfolio

0.16%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $396,809 - $500,496	-5,959 Reduced 5.3%	106,575 $8.93 Million
Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $751,421 - $867,199	-11,899 Reduced 9.56%	112,534 $7.72 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $663,976 - $809,702	9,276 Added 8.06%	124,433 $9.11 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $98,255 - $111,423	-1,341 Reduced 1.15%	115,157 $9.33 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $334,874 - $365,354	4,529 Added 4.04%	116,498 $8.73 Million
Q2 2023 Aug 21, 2023	SELL	$76.01 - $86.7 $289,826 - $330,587	-3,813 Reduced 3.29%	111,969 $8.63 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $507,694 - $578,421	-6,567 Reduced 5.37%	115,782 $9.61 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $123,518 - $177,329	-1,982 Reduced 1.59%	122,349 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $534,788 - $610,865	-8,982 Reduced 6.74%	124,331 $7.67 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $51,717 - $58,248	896 Added 0.68%	133,313 $8.24 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $557,769 - $698,945	9,630 Added 7.84%	132,417 $7.87 Million
Q4 2021 Mar 11, 2022	BUY	$64.88 - $73.64 $3.29 Million - $3.73 Million	50,642 Added 70.19%	122,787 $8.92 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $779,585 - $841,086	11,517 Added 19.0%	72,145 $5.04 Million
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $2.46 Million - $2.81 Million	-41,008 Reduced 40.35%	60,628 $3.92 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.13 Million - $2.43 Million	-37,585 Reduced 27.0%	101,636 $5.92 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $1.32 Million - $1.66 Million	-21,265 Reduced 13.25%	139,221 $8.8 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $2.56 Million - $2.97 Million	35,394 Added 28.29%	160,486 $12.3 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $639,640 - $819,286	-10,213 Reduced 7.55%	125,092 $9.35 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $160,581 - $176,634	2,606 Added 1.96%	135,305 $8.79 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $2.27 Million - $2.51 Million	36,348 Added 37.72%	132,699 $8.41 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $6,681 - $7,493	108 Added 0.11%	96,351 $6.51 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $442,587 - $495,813	7,078 Added 7.94%	96,243 $6.26 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $1.1 Million - $1.44 Million	-18,222 Reduced 16.97%	89,165 $5.58 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $965,701 - $1.07 Million	-13,548 Reduced 11.2%	107,387 $8.29 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $139,232 - $162,409	2,146 Added 1.81%	120,935 $8.57 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $73,204 - $89,244	-1,005 Reduced 0.84%	118,789 $8.96 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.55 Million - $1.82 Million	21,768 Added 22.21%	119,794 $8.58 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.51 Million - $4.16 Million	48,634 Added 98.47%	98,026 $7.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	49,392	49,392 $3.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account